{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T05:07:25Z","timestamp":1775797645653,"version":"3.50.1"},"reference-count":41,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T00:00:00Z","timestamp":1775779200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Pediatric acute myeloid leukemia (pAML) is a rapidly progressive myeloid malignancy characterized by malignant clonal expansion of hematopoietic stem and progenitor cells. The prediction of complete remission (CR) and first adverse event (AE) is critical for personalizing pAML treatment; however, interpretable machine learning (ML) models that utilize only routine clinical features for this purpose are lacking.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      A total of 206\n                      <jats:italic>de novo<\/jats:italic>\n                      pediatric AML patients (excluding acute promyelocytic leukemia) were randomly split into training (80%) and test (20%) sets. Seven supervised ML algorithms were constructed for predicting CR and AE, and their performance was evaluated by accuracy, specificity, F1-score, and area under the receiver operating characteristic curve (AUC). Model interpretability was assessed using feature importance, accumulated local effect (ALE) plots, and SHAP values.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>To identify optimal predictors of CR, three feature selection methods-random forest, stepwise regression, and joint mutual information maximization (JMIM)-were employed. Their intersection revealed seven key features: age, bone marrow blasts, peripheral blood blasts, platelet count (PLT), t (8;21), TP53 and del7\/del7q. The random forest model demonstrated optimal performance, with a training AUC of 0.90 (95% CI: 0.86-0.97) and a test AUC of 0.79 (95% CI: 0.72-0.86). The similar machine learning pipeline was applied to predict the first adverse event (AE). Nine features were selected as optimal predictors through the intersection of the same three algorithms: white blood cell count (WBC), peripheral blood blasts, PLT, bone marrow blasts, hemoglobin, age, t (8;21), NPM1 and KIT. For AE prediction, the random forest algorithm also exhibited optimal performance, with a training AUC of 0.92 (95% CI: 0.85-0.97) and a test AUC of 0.78 (95% CI: 0.66-0.84). Interpretability analysis of the random forest models revealed that a higher platelet count at diagnosis was predictive of an increased probability of CR and a reduced risk of AE. In contrast, elevated WBC and peripheral blood blast percentage were associated with a higher incidence of AE.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Our random forest model, built on routine hematological parameters, demonstrated strong potential for predicting CR and AE in pAML, thereby facilitating early risk stratification and guiding personalized treatment strategies.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fonc.2026.1739432","type":"journal-article","created":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T04:26:08Z","timestamp":1775795168000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Development of an interpretable machine learning model to predict complete remission and first adverse event in pediatric acute myeloid leukemia using routine clinical data"],"prefix":"10.3389","volume":"16","author":[{"given":"Ningshu","family":"Huang","sequence":"first","affiliation":[{"name":"Department of Clinical Laboratory, Children\u2019s Hospital of Chongqing Medical University, National Clinical Research Center for Children and Adolescents' Health and Diseases, Ministry of Education Key Laboratory of Child Development and Disorders, Chongqing Key Laboratory of Pediatrics Metabolism and Inflammatory Diseases, Laboratory for clinical diagnostic and translational research of CHCQMU","place":["Chongqing, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weiwei","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of the Clinical molecular Center, Children's Hospital of Chongqing Medical University, National Clinical Research Center for Children and Adolescents' Health and Disorders, Ministry of Education Key Laboratory of Child Development and Disorders, Chongqing Key Laboratory of Pediatrics Metabolism and Inflammatory Diseases, Laboratory for clinical diagnostic and translational research of CHCQMU","place":["Chongqing, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rui","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of the Clinical molecular Center, Children's Hospital of Chongqing Medical University, National Clinical Research Center for Children and Adolescents' Health and Disorders, Ministry of Education Key Laboratory of Child Development and Disorders, Chongqing Key Laboratory of Pediatrics Metabolism and Inflammatory Diseases, Laboratory for clinical diagnostic and translational research of CHCQMU","place":["Chongqing, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhihong","family":"Liao","sequence":"additional","affiliation":[{"name":"Department of the Clinical molecular Center, Children's Hospital of Chongqing Medical University, National Clinical Research Center for Children and Adolescents' Health and Disorders, Ministry of Education Key Laboratory of Child Development and Disorders, Chongqing Key Laboratory of Pediatrics Metabolism and Inflammatory Diseases, Laboratory for clinical diagnostic and translational research of CHCQMU","place":["Chongqing, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hui","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Hematology, Children\u2019s Hospital of Chongqing Medical University, National Clinical Research Center for Children and Adolescents' Health and Disorders, Ministry of Education Key Laboratory of Child Development and Disorders, Chongqing Key Laboratory of Pediatrics Metabolism and Inflammatory Diseases","place":["Chongqing, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xi","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of the Clinical molecular Center, Children's Hospital of Chongqing Medical University, National Clinical Research Center for Children and Adolescents' Health and Disorders, Ministry of Education Key Laboratory of Child Development and Disorders, Chongqing Key Laboratory of Pediatrics Metabolism and Inflammatory Diseases, Laboratory for clinical diagnostic and translational research of CHCQMU","place":["Chongqing, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2026,4,10]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2016-08-733196","article-title":"Diagnosis and management of aml in adults: 2017 eln recommendations from an international expert panel","volume":"129","author":"Dohner","year":"2017","journal-title":"Blood"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.33878","article-title":"Increased survival disparities among children and adolescents & young adults with acute myeloid leukemia: A dutch population-based study","volume":"150","author":"Schulpen","year":"2022","journal-title":"Int J Cancer"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2025.1466818","article-title":"Prognostic factors and outcomes in pediatric acute myeloid leukemia: A comprehensive bibliometric analysis of global research trends","volume":"15","author":"Rao","year":"2025","journal-title":"Front Oncol"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.15799","article-title":"Clinical and biological features of paediatric acute myeloid leukaemia (aml) with primary induction failure in the Japanese paediatric leukaemia\/lymphoma study group aml-05 study","volume":"185","author":"Miyamura","year":"2019","journal-title":"Br J Haematol"},{"key":"B5","doi-asserted-by":"publisher","first-page":"4797","DOI":"10.1182\/blood-2018-99-119185","article-title":"Transplant rates and outcomes of young acute myeloid leukemia (aml) patients with intermediate and poor risk disease referred to a coordinated acute leukemia and hematopoietic stem cell transplant (hsct) program","volume":"132","author":"Solh","year":"2018","journal-title":"Blood"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2010-01-261800","article-title":"A review on allogeneic stem cell transplantation for newly diagnosed pediatric acute myeloid leukemia","volume":"116","author":"Niewerth","year":"2010","journal-title":"Blood"},{"key":"B7","unstructured":"Acute myeloid leukemia: Children and adolescents\n          \n          \n          \n          2024"},{"key":"B8","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1080\/14737140.2021.1841640","article-title":"Pediatric relapsed acute myeloid leukemia: A systematic review","volume":"21","author":"Hoffman","year":"2021","journal-title":"Expert Rev Anticancer Ther"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.3390\/cancers15123112","article-title":"Bone marrow microenvironment-induced chemoprotection in rearranged pediatric aml is overcome by azacitidine-panobinostat combination","volume":"15","author":"Lehner","year":"2023","journal-title":"Cancers"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2024534","article-title":"Genome sequencing as an alternative to cytogenetic analysis in myeloid cancers","volume":"384","author":"Duncavage","year":"2021","journal-title":"New Engl J Med"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2024.285644","article-title":"Novel classification system and high-risk categories of pediatric acute myeloid leukemia","volume":"110","author":"Umeda","year":"2025","journal-title":"Haematologica"},{"key":"B12","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1038\/sj.leu.2401241","article-title":"Internal tandem duplication of the gene and clinical evaluation in childhood acute myeloid leukemia","volume":"13","author":"Iwai","year":"1999","journal-title":"Leukemia"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa074306","article-title":"Mutations and treatment outcome in cytogenetically normal acute myeloid leukemia","volume":"358","author":"Schlenk","year":"2008","journal-title":"New Engl J Med"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.21873\/anticanres.15951","article-title":"Improved outcome in pediatric acute myeloid leukemia: Progress with hematopoietic cell transplantation","volume":"42","author":"Stankiewicz","year":"2022","journal-title":"Anticancer Res"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1507471","article-title":"Assessment of minimal residual disease in standard-risk aml","volume":"374","author":"Ivey","year":"2016","journal-title":"N Engl J Med"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1002\/cpt.1796","article-title":"An introduction to machine learning","volume":"107","author":"Badillo","year":"2020","journal-title":"Clin Pharmacol Ther"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1038\/s41746-022-00651-4","article-title":"Identification of robust deep neural network models of longitudinal clinical measurements","volume":"5","author":"Javidi","year":"2022","journal-title":"NPJ Digit Med"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.aau6792","article-title":"Machine learning in a data-limited regime: Augmenting experiments with synthetic data uncovers order in crumpled sheets","volume":"5","author":"Hoffmann","year":"2019","journal-title":"Sci Adv"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCOUTCOMES.120.006556","article-title":"Recommendations for reporting machine learning analyses in clinical research","volume":"13","author":"Stevens","year":"2020","journal-title":"Circ-Cardiovasc Qual"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2009-03-209262","article-title":"The 2008 revision of the world health organization (who) classification of myeloid neoplasms and acute leukemia: Rationale and important changes","volume":"114","author":"Vardiman","year":"2009","journal-title":"Blood"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2016-03-643544","article-title":"The 2016 revision to the world health organization classification of myeloid neoplasms and acute leukemia","volume":"127","author":"Arber","year":"2016","journal-title":"Blood"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.3760\/cma.j.issn.0578-1310.2006.11.124","article-title":"Recommendations for diagnosis and treatment of acute myelocytic leukemia in children","volume":"11","author":"Longjun","year":"2006","journal-title":"Zhonghua Er Ke Za Zhi"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.3969\/j.issn.1009-5519.2021.20.020","article-title":"Research progress on the relationship between measurable residual disease and treatment response as well as prognosis in childhood acute myeloid leukemia","volume":"37","author":"Ya","year":"2021","journal-title":"J Modern Med Health"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2012-03-362608","article-title":"Diagnosis and management of acute myeloid leukemia in children and adolescents: Recommendations from an international expert panel","volume":"120","author":"Creutzig","year":"2012","journal-title":"Blood"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2017-03-772384","article-title":"Genomic architecture and treatment outcome in pediatric acute myeloid leukemia: A children's oncology group report","volume":"129","author":"Vujkovic","year":"2017","journal-title":"Blood"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1038\/nrg3920","article-title":"Machine learning applications in genetics and genomics","volume":"16","author":"Libbrecht","year":"2015","journal-title":"Nat Rev Genet"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.30260","article-title":"Leveraging machine learning to identify acute myeloid leukemia patients and their chemotherapy regimens in an administrative database","volume":"70","author":"Cao","year":"2023","journal-title":"Pediatr Blood Cancer"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-024-12646-3","article-title":"Artificial intelligence reveals the predictions of hematological indexes in children with acute leukemia","volume":"24","author":"Cheng","year":"2024","journal-title":"BMC Cancer"},{"key":"B29","doi-asserted-by":"publisher","first-page":"690","DOI":"10.3324\/haematol.2021.280027","article-title":"Prediction of complete remission and survival in acute myeloid leukemia using supervised machine learning","volume":"108","author":"Eckardt","year":"2023","journal-title":"Haematologica"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1177\/1176935119835544","article-title":"Predicting complete remission of acute myeloid leukemia: Machine learning applied to gene expression","volume":"18","author":"Gal","year":"2019","journal-title":"Cancer Inform"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1101\/2020.04.16.20068221","article-title":"Machine learning to predict 5-year survival among pediatric acute myeloid leukemia patients and development of ospam-c online survival prediction tool","author":"Ashis Kumar Das","year":"2020","journal-title":"medRxiv"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1016\/s0895-4356(98)90044-0","article-title":"An analysis of prognostic factors for acute leukemia patients with 5-year long-term survival in shanghai","volume":"38","author":"Wang","year":"1999","journal-title":"Zhonghua Nei Ke Za Zhi"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.7717\/peerj.4139","article-title":"Pretreatment platelet count predicts survival outcome of patients with de novo non-m3 acute myeloid leukemia","volume":"5","author":"Zhang","year":"2017","journal-title":"PeerJ"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1080\/10428190600572673","article-title":"Leukocyte count as a predictor of death during remission induction in acute myeloid leukemia","volume":"47","author":"Greenwood","year":"2006","journal-title":"Leuk Lymphoma"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.14692","article-title":"Hyperleucocytosis in paediatric acute myeloid leukaemia - the challenge of white blood cell counts above 200 x 10(9) \/l. The nopho experience 1984-2014","volume":"178","author":"Zeller","year":"2017","journal-title":"Br J Haematol"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2004.01.191","article-title":"Early deaths and treatment-related mortality in children undergoing therapy for acute myeloid leukemia: Analysis of the multicenter clinical trials aml-bfm 93 and aml-bfm 98","volume":"22","author":"Creutzig","year":"2004","journal-title":"J Clin Oncol"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2012.065490","article-title":"Predictors and short-term outcomes of hyperleukocytosis in children with acute myeloid leukemia: A report from the children's oncology group","volume":"97","author":"Sung","year":"2012","journal-title":"Haematologica"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.18685","article-title":"Characteristics and outcome of primary resistant disease in paediatric acute myeloid leukaemia","volume":"201","author":"Karlsson","year":"2023","journal-title":"Br J Haematol"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1002\/ece3.6786","article-title":"Sdmtune: An r package to tune and evaluate species distribution models","volume":"10","author":"Vignali","year":"2020","journal-title":"Ecol Evol"},{"key":"B40","doi-asserted-by":"publisher","first-page":"7186","DOI":"10.1038\/s41467-022-34965-4","article-title":"Inflammatory bone marrow signaling in pediatric acute myeloid leukemia distinguishes patients with poor outcomes","volume":"13","author":"Bolouri","year":"2022","journal-title":"Nat Commun"},{"key":"B41","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1111\/bjh.13107","article-title":"Prognostic factors in children with acute myeloid leukaemia and excellent response to remission induction therapy","volume":"168","author":"Karol","year":"2015","journal-title":"Br J Haematol"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2026.1739432\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T04:26:10Z","timestamp":1775795170000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2026.1739432\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,10]]},"references-count":41,"alternative-id":["10.3389\/fonc.2026.1739432"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2026.1739432","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,10]]},"article-number":"1739432"}}